OncoSec Medical Inc (ONCSQ)

[lasers]

IMO UCSF decision to be 100% sponsor for $ONCS and Keytruda Combo is doing the same by footing the total costs. UCSF Mt. Zion medical center expecting to reap the benefits.


http://mountzion.ucsfmedicalcenter.org/

http://cancer.ucsf.edu/about/contact-information

UCSF Helen Diller Family Comprehensive Cancer Center

https://clinicaltrials.gov/ct2/show/NCT02493361?term=UCSF+and+keytruda&rank=2

http://cancer.ucsf.edu/clinical-trials/melanoma

Protocol Summary

[ Back to Protocol Listing ]


[ Print this page ]

Protocol No. 15852 Principal Investigator Algazi, Alain
Phase II (Cancer Control)
Age Group Adult Scope National
Title An Open-label, Phase II, Multicenter Study of Enhancing Pembrolizumab Responses in Melanoma through Intratumoral pIL-12 Electroporation
Applicable Disease Sites Melanoma, skin
Drugs Involved IL-12 Plasmid (Interleukin-12)
MK-3475
Status Open
Participating Institutions Mt. Zion